Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

MSPS Focuses on Design of New Lens Production Facility

Published: Saturday, March 15, 2014
Last Updated: Friday, March 14, 2014
Bookmark and Share
Company has won a significant contract to support the design of new facility.

Morgan Sindall Professional Services (MSPS) has won a significant contract for a world-leading life sciences business to support the design and build of a new, best-in-class production facility for completion in 2015.

Rayner Intraocular Lenses, whose products have been used to surgically restore the sight of millions of people worldwide, are building a new facility to meet global demand. MSPS is providing the civil and structural, process, mechanical and electrical, architectural, BREEAM and CDM services for the new development.

The consultancy, which has designed over 2 million sq ft of clean room space over the past 20 years, was tasked with developing options for the refurbishment of an alternative building as well as the selected option of a new, highly-efficient facility.

The new brownfield development is close enough to Rayner’s existing facility to retain its highly skilled, specialized workforce and the consultancy will support a phased occupation to take place, ensuring no interruption to production.

Mark Dickson, director for manufacturing and life sciences says that MSPS was chosen for its leading experience in complex manufacturing: “We have delivered a design that makes intelligent use of internal space to ensure increased output and a reduction in operating costs. Our design goes beyond building regulations to reduce energy consumption, which is detailed on a per lens basis,” he explains.

“The facility is designed to achieve BREEAM ‘very good’ status for the low carbon technology used in the facility.”

Good Manufacturing Practice (GMP) is key to the design of the new facility, and integral to all aspects of the building including its use of space, operation, the materials used and their cleaning and maintenance.

MSPS’ front-end engineering and process skills were employed to develop User Requirement Specifications (URS) and the multidisciplinary design solution was developed in a BIM environment, co-ordinated through Revit in order that MSPS could clearly and visually communicate the design’s attributes and benefits.

Part of the process engineering consultation was in the design of bespoke equipment; MSPS’ role was to identify the equipment specification and effectively translate these detailed and exacting requirements to the supplying vendors. This equipment will deliver the greatest efficiency and benefits to the business’ production.

Martin Jamieson, Rayner CEO commented that implantable medical devices are subject to rigorous technical and quality standards, imposed by the regulatory authorities around the world: “In partnership with MSPS Rayner will deliver a state-of-the-art manufacturing facility producing intraocular lenses for sale to markets worldwide. The decision to base the facility in the UK is a tribute to the quality and productivity leap that will be achieved in this country. Rayner will also move its global headquarters to the new facility.”

The detail design phase will be completed in early 2014, allowing the start of construction, which is due for completion in October 2015.

Rayner Intraocular Lenses is the only manufacturer of intraocular lenses in the UK. The company is a member of the Rayner group of companies which has had interests in optics since it was established in 1910.

Having predicted reaching maximum production capacity in its existing facility, Rayner put out to tender a brief that would future proof its production capabilities.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos